Table 2.
Most commonly detected antibiotic resistance genes and associated antibiotic resistance phenotypes by time point
| Antibiotic resistance profile and associated antibiotic resistance genes | Timepoint | ||||
|---|---|---|---|---|---|
| W3 (n = 28) No. (%) |
M3 (n = 41) No. (%) |
M6 (n = 58) No. (%) |
M12 (n = 61) No. (%) |
||
| Fosfomycin | fosA | 27 (96.43%) | 34 (82.93%) | 47 (81.03%) | 37 (60.66%) |
| Beta-lactam | blaZ | 27 (96.43%) | 16 (39.02%) | 12 (20.69%) | 8 (13.11%) |
| Tetracycline | tet(M) | 20 (71.43%) | 26 (63.41%) | 35 (60.34%) | 38 (62.30%) |
| Macrolide | mef(A) | 19 (67.86%) | 31 (75.61%) | 46 (79.31%) | 57 (93.44%) |
| Quinolone | oqxB | 19 (67.86%) | 24 (58.54%) | 23 (39.66%) | 14 (22.95%) |
| Quinolone | msr(D) | 18 (64.29%) | 28 (68.29%) | 47 (81.03%) | 53 (86.89%) |
| Macrolide | erm(B) | 17 (60.71%) | 26 (63.41%) | 48 (82.76%) | 54 (88.52%) |
| Macrolide | lsa(A) | 17 (60.71%) | 32 (78.05%) | 29 (50%) | 5 (8.20%) |
| Tetracycline | tet(W) | 15 (53.57%) | 31 (75.61%) | 51 (87.93%) | 50 (81.97%) |
| Aminoglycoside | aac(6′)-aph(2″) | 15 (53.57%) | 10 (24.39%) | 21 (36.21%) | 34 (55.74%) |
The number and percentage of subjects with the antibiotic resistance genes are shown